Cite
HARVARD Citation
Honda, T. et al. (n.d.). 1403POpen-label multicenter randomized phase II study of docetaxel plus bevacizumab or pemetrexed plus bevacizumab for elderly (≥75 years old) patients (pts) with previously untreated advanced non-squamous non-small cell lung cancer (NSCLC): TORG1323. Annals of oncology. p. . [Online].